CLINICAL_TRIALS
trial_result
· 2013-12-20
Clinical Trial Update: Timed-Sequential Induction in CBF-AML [Phase 3]
Summary
A Phase 3 clinical trial evaluating timed-sequential induction in core-binding factor acute myeloid leukemia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Acute Myeloid Leukemia | Phase 3 | Status: COMPLETED